Latest California Healthline Stories
Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.
New research not only confirms the heart health benefits of a Mediterranean-style diet, but also tracks these benefits over the long term.
And new study finds no reason to get routine vitamin D tests, researchers say.
Critics worry the marketing of Vascepa, a purified fish oil product, could prove a fish story.
Overall, Californians are beating cancer for longer due to earlier detection and better treatment of the disease, a new study reveals. But the gains are not felt equally: Whites fare better than blacks, and younger patients better than older.
State Sen. Richard Pan, a pediatrician who still sees patients once a week, is the new chairman of the Senate Health Committee. He takes this leadership role as he seeks re-election and as the state is battling federal cuts and preparing for a new governor.
On April 1, Medicare launched a major initiative — a diabetes prevention program for seniors and people with serious disabilities— that is available in only a few cities.
An abortion drug invented decades ago is being used to treat Cushing’s syndrome — and it’s bringing in tens of millions of dollars a year.
Health care professionals increasingly collaborate with anti-abuse advocates to identify victims and ensure they get the help they need. One women’s center is opening a shelter on the campus of a large public hospital in Los Angeles.
The price for Pfizer’s Prevnar 13 has increased 5 to 6 percent each year since its 2010 approval by the Food and Drug Administration.